Study: Many cancer drugs unproven 5 years after accelerated approval
Time:2024-05-22 00:10:05 Source:opinionsViews(143)
The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives?
In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years.
“Five years after the initial accelerated approval, you should have a definitive answer,” said Dr. Ezekiel Emanuel, a cancer specialist and bioethicist at the University of Pennsylvania who was not involved in the research. “Thousands of people are getting those drugs. That seems a mistake if we don’t know whether they work or not.”
The program was created in 1992 to speed access to HIV drugs. Today, 85% of accelerated approvals go to cancer drugs.
It allows the FDA to grant early approval to drugs that show promising initial results for treating debilitating or fatal diseases. In exchange, drug companies are expected to do rigorous testing and produce better evidence before gaining full approval.
Previous:Rays opening
Next:Brewers starter Joe Ross leaves after first inning vs. Marlins with lower back strain
You may also like
- Candice Swanepoel stuns in a form
- Mexico denounces Ecuador to ICJ for embassy raid
- Firm career path enables Kenyan man to find feet in society
- Boss apologizes for UK city's bankruptcy
- Philippines blames China for loss of giant clams in disputed shoal and urges environmental inquiry
- Chinese President Appoints New Ambassadors
- Beijing calls for restoring dialogue
- Xi Orders Curbing Repeated Occurrence of Safety Accidents After Deadly Street Shop Fire
- Young Boys seals 6th Swiss soccer league title in 7 years after rallying from firing coach Wicky